Major Wall Street indexes closed lower on Tuesday as investors booked some profits from a post-election rally and turned ...

Richmond Fed President Thomas Barkin said earlier in the day that the U.S. central bank is ready to respond if inflation ...

Novavax's 2nd round of job cuts reached 12% of staff, though execs say that should be it for now That deal saw Novavax retain the rights to its combo COVID-flu vaccine, while Sanofi has the sole ...

Amgen stock price tanked 7%, Novavax shares plunged 6% ... in the day that the US central bank is ready to respond if ...

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong ...

The U.S. central bank is ready to respond if inflation pressures rise or the job market weakens ... despite forecasting a ...

Wall Street's main indexes fell on Tuesday as investors booked profits from post-election gains and awaited U.S. inflation ...

The latest update is out from Novavax ( (NVAX)). Novavax, a leader in vaccine development, announced the FDA’s removal of a clinical hold on their COVID-19-Influenza combination and influenza vaccine ...

Besides Sanofi deal for nuvaxovid, Novavax has few opportunities to generate additional revenue, which likely means its stock ...

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Novavax Inc. (NVAX) on Tuesday reported a loss of $121.3 million in its third quarter. On a per-share basis, the Gaithersburg, Maryland-based company ...

Novavax (NVAX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.